Developing a Bone-Mimicking Microenvironment: Surface Coating Method for Investigating Bone Remodeling in Vitro
Source abstract
Abstract
High Resolution Image Download MS PowerPoint Slide To investigate bone formation and resorption in vitro, it is essential to create bone-like microenvironments on cell culture substrates. Here, we present a coating technique to create such a microenvironment on cell culture plastic (CCP) multiwell plates for studying bone remodeling in vitro . Utilizing this coating, we have developed an assay to simultaneously measure cellular mineral formation and resorption in osteoblast and osteoclast coculture models. A composite matrix of collagen type I and carbonated apatitic calcium phosphate was deposited onto CCP in a reproducible manner using a 10× simulated body fluid solution (SBF) supplemented with type I collagen. qPCR analysis and cellular imaging using fluorescence microscopy demonstrated the promotion of osteogenic differentiation, cell attachment, and proliferation of human bone-marrow-derived mesenchymal stem cells on coated substrates. Moreover, human bone-marrow-derived mononuclear cells successfully differentiated into osteoclasts and resorbed the coated substrate. Using the developed coating, an osteoblast and osteoclast coculture system was established, enabling real-time monitoring of mineral formation and resorption. By providing a controlled and physiologically relevant in vitro model, this assay facilitates the screening of therapeutic compounds, the study of bone cell interactions, and the identification of factors influencing bone remodeling, thereby enhancing translational research in bone health.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone Metabolism and Diseases · Bone and Dental Protein Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Newcastle University
AO Research Institute Davos
University Hospital Knappschaftskrankenhaus Bochum
Mines Saint-Étienne, INSERM, U1059 Sainbiose
Funding
Engineering and Physical Sciences Research Council · Newcastle University · AO Research Institute Davos, Switzerland
References (50)
Show source-provided references
1. 10.2215/CJN.0415120610.2215/CJN.04151206 ↗
2. 10.1146/annurev-physiol-021119-03442510.1146/annurev-physiol-021119-034425 ↗
3. Rosen, C. J. In The Epidemiology and Pathogenesis of Osteoporosis; De Groot, L. J., Chrousos, G, Dungan, K, Eds. MDText.com, Inc., South Dartmouth, MA; 2000–2017; Endotext [Internet], Vol. 3, pp 112–119.
4. 10.1177/02611929070350061010.1177/026119290703500610 ↗
5. Osteoporosis: Nonclinical Evaluation of Drugs Intended for Treatment. Guidance for Industry; FDA, 2016, August, pp 1–8.
6. Guideline on the Evaluation of Medicinal Products in the Treatment of Primary Osteoporosis; European Medicines Agency, 2006; pp 1–10.
7. 10.1016/S0020-1383(16)30002-X10.1016/S0020-1383(16)30002-X ↗
8. 10.1080/17460441.2018.148060910.1080/17460441.2018.1480609 ↗
9. 10.1359/jbmr.08051610.1359/jbmr.080516 ↗
10. 10.22203/eCM.v024a2710.22203/eCM.v024a27 ↗
11. Russell W. M. S. · 1958
12. 10.3390/ijms2103091210.3390/ijms21030912 ↗
13. 10.1002/jbm.a.3285610.1002/jbm.a.32856 ↗
14. 10.1089/ten.2006.12.94910.1089/ten.2006.12.949 ↗
15. 10.1002/jcp.2607610.1002/jcp.26076 ↗
16. 10.3390/jfmk301001710.3390/jfmk3010017 ↗
17. 10.1016/j.biomaterials.2014.01.03410.1016/j.biomaterials.2014.01.034 ↗
18. 10.1007/BF0189848410.1007/BF01898484 ↗
19. 10.1186/s12575-018-0079-410.1186/s12575-018-0079-4 ↗
20. 10.1021/bp060274b10.1021/bp060274b ↗
21. 10.1089/ten.tec.2017.040010.1089/ten.tec.2017.0400 ↗
22. 10.22203/eCM.v040a1210.22203/eCM.v040a12 ↗
23. 10.1557/JMR.2004.034910.1557/JMR.2004.0349 ↗
24. 10.1007/978-1-0716-2839-3_610.1007/978-1-0716-2839-3_6 ↗
25. 10.1038/sj.embor.740074010.1038/sj.embor.7400740 ↗
26. 2006
27. Jaworski Z. F. · J. Anat. · 1980 · 131 · 91
28. Jaworski Z. F. · J. Anat. · 1981 · 133 · 397
29. Gruber H. E. · Miner. Electrolyte Metab. · 1986 · 12 · 246
30. 10.3390/ijms2209478510.3390/ijms22094785 ↗
31. 10.1089/ten.tea.2014.009610.1089/ten.tea.2014.0096 ↗
32. 10.1016/j.biomaterials.2007.02.02810.1016/j.biomaterials.2007.02.028 ↗
33. 10.1016/j.jmrt.2020.04.08910.1016/j.jmrt.2020.04.089 ↗
34. 10.1016/j.biomaterials.2004.02.03010.1016/j.biomaterials.2004.02.030 ↗
35. 10.1021/la904406b10.1021/la904406b ↗
36. 10.1016/j.actbio.2010.07.03710.1016/j.actbio.2010.07.037 ↗
37. 10.1074/jbc.275.1.3510.1074/jbc.275.1.35 ↗
38. 10.1038/273345a010.1038/273345a0 ↗
39. 10.1016/j.colsurfb.2016.08.02010.1016/j.colsurfb.2016.08.020 ↗
40. 10.1163/092050610X51424110.1163/092050610X514241 ↗
41. 10.1186/s12896-014-0105-910.1186/s12896-014-0105-9 ↗
42. 10.3389/fbioe.2020.55456510.3389/fbioe.2020.554565 ↗
43. 10.3389/fcell.2020.61057010.3389/fcell.2020.610570 ↗
44. 10.1186/1479-5876-2-610.1186/1479-5876-2-6 ↗
45. 10.1016/j.actbio.2016.12.01310.1016/j.actbio.2016.12.013 ↗
46. 10.1016/j.actbio.2019.06.05710.1016/j.actbio.2019.06.057 ↗
47. 10.1371/journal.pone.025772410.1371/journal.pone.0257724 ↗
48. 10.1002/term.155910.1002/term.1559 ↗
49. 10.1016/j.bonr.2022.10164610.1016/j.bonr.2022.101646 ↗
50. 10.1016/j.clinbiochem.2012.03.02110.1016/j.clinbiochem.2012.03.021 ↗